Fionda Bruno, Loperfido Antonella, Di Stefani Alessandro, Lancellotta Valentina, Paradisi Andrea, De Angeli Martina, Cappilli Simone, Rossi Ernesto, Caretto Anna Amelia, Zinicola Tiziano, Schinzari Giovanni, Gentileschi Stefano, Morganti Alessio Giuseppe, Rembielak Agata, Peris Ketty, Tagliaferri Luca
U.O.C. Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica Ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
Otolaryngology Unit, San Camillo Forlanini Hospital, 00152 Rome, Italy.
J Clin Med. 2024 Mar 21;13(6):1798. doi: 10.3390/jcm13061798.
: Dermatofibrosarcoma protuberans (DFSP) is a superficial soft tissue sarcoma, and surgical excision is the first-line treatment. The aim of this systematic review is to provide an update about the current indications and clinical results regarding the use of postoperative radiotherapy in DSFP, considering both adjuvant and salvage setting. : We conducted a systematic literature review using the main scientific database, including Cochrane library, Scopus, and PubMed, for any relevant article about the topic, and we considered all available papers without any time restriction. : Twenty-two papers, published between 1989 and 2023, were retrieved and considered eligible for inclusion in this review. Regarding the fractionation schedules, most authors reported using standard fractionation (2 Gy/die) with a wide total dose ranging from 50 to 70 Gy. The local control after postoperative radiotherapy was excellent (75-100%), with a median follow-up time of 69 months. : After the primary surgical management of DFSP, postoperative radiotherapy may either be considered as adjuvant treatment (presence of risk factors, i.e., close margins, recurrent tumours, aggressive histological subtypes) or as salvage treatment (positive margins) and should be assessed within the frame of multidisciplinary evaluation.
隆突性皮肤纤维肉瘤(DFSP)是一种浅表软组织肉瘤,手术切除是一线治疗方法。本系统评价的目的是提供关于DFSP术后放疗当前适应证和临床结果的最新信息,同时考虑辅助治疗和挽救性治疗情况。
我们使用主要科学数据库进行了系统的文献综述,包括Cochrane图书馆、Scopus和PubMed,以查找有关该主题的任何相关文章,并且我们考虑了所有无时间限制的可用论文。
检索到1989年至2023年间发表的22篇论文,并认为它们符合纳入本综述的条件。关于分割方案,大多数作者报告使用标准分割(2 Gy/次),总剂量范围广泛,为50至70 Gy。术后放疗后的局部控制效果极佳(75%-100%),中位随访时间为69个月。
在DFSP的初次手术治疗后,术后放疗可被视为辅助治疗(存在危险因素,即切缘接近、肿瘤复发、侵袭性组织学亚型)或挽救性治疗(切缘阳性),并且应在多学科评估框架内进行评估。